| Term | Count | % | P-value | Benjamini |
---|---|---|---|---|---|
Upregulated in NCMs | Metabolism | 143 | 25.9 | 1.30E − 13 | 1.60E − 10 |
Complex I biogenesis | 17 | 3.1 | 1.70E − 10 | 1.00E − 07 | |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins | 20 | 3.6 | 2.50E − 07 | 7.90E − 05 | |
Respiratory electron transport | 18 | 3.3 | 2.50E − 07 | 7.90E − 05 | |
Cholesterol biosynthesis | 10 | 1.8 | 3.50E − 07 | 8.80E − 05 | |
The citric acid (TCA) cycle and respiratory electron transport | 23 | 4.2 | 8.60E − 07 | 1.80E − 04 | |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 12 | 2.2 | 5.00E − 06 | 8.90E − 04 | |
Activation of gene expression by SREBF (SREBP) | 10 | 1.8 | 2.00E − 05 | 3.20E − 03 | |
Metabolism of lipids | 50 | 9.1 | 7.70E − 05 | 1.10E − 02 | |
Response to elevated platelet cytosolic Ca2 +  | 16 | 2.9 | 1.50E − 04 | 1.90E − 02 | |
Localization of the PINCH-ILK-PARVIN complex to focal adhesions | 4 | 0.7 | 2.10E − 04 | 2.30E − 02 | |
Platelet degranulation | 15 | 2.7 | 3.40E − 04 | 3.50E − 02 | |
Cell-extracellular matrix interactions | 6 | 1.1 | 4.20E − 04 | 4.00E − 02 | |
Apoptotic execution phase | 9 | 1.6 | 6.60E − 04 | 5.80E − 02 | |
RHO GTPase cycle | 32 | 5.8 | 8.00E − 04 | 6.60E − 02 | |
Innate immune system | 61 | 11.1 | 9.20E − 04 | 7.10E − 02 | |
Metabolism of steroids | 15 | 2.7 | 2.00E − 03 | 1.20E − 01 | |
Membrane trafficking | 38 | 6.9 | 5.10E − 03 | 2.50E − 01 | |
Cell junction organization | 11 | 2 | 6.90E − 03 | 3.10E − 01 | |
Vesicle-mediated transport | 39 | 7.1 | 7.80E − 03 | 3.30E − 01 | |
Cell–cell communication | 13 | 2.4 | 8.50E − 03 | 3.30E − 01 | |
Metabolism of carbohydrates | 21 | 3.8 | 8.50E − 03 | 3.30E − 01 | |
Apoptosis induced DNA fragmentation | 4 | 0.7 | 1.10E − 02 | 4.00E − 01 | |
Apoptotic cleavage of cellular proteins | 6 | 1.1 | 1.30E − 02 | 4.40E − 01 | |
Immune system | 95 | 17.2 | 1.40E − 02 | 4.40E − 01 | |
Programmed cell death | 16 | 2.9 | 1.50E − 02 | 4.50E − 01 | |
Fatty acid metabolism | 14 | 2.5 | 1.60E − 02 | 4.90E − 01 | |
Signaling by VEGF | 10 | 1.8 | 2.00E − 02 | 5.30E − 01 | |
Integrin cell surface interactions | 8 | 1.4 | 4.10E − 02 | 9.00E − 01 | |
Biological oxidations | 15 | 2.7 | 4.10E − 02 | 9.00E − 01 | |
Upregulated in UMs | Metabolism of RNA | 27 | 14.1 | 1.40E − 07 | 9.70E − 05 |
Processing of capped intron-containing pre-mRNA | 13 | 6.8 | 1.10E − 04 | 3.80E − 02 | |
Translation | 12 | 6.3 | 5.70E − 04 | 1.10E − 01 | |
mRNA splicing—major pathway | 10 | 5.2 | 6.70E − 04 | 1.10E − 01 | |
tRNA aminoacylation | 4 | 2.1 | 1.30E − 02 | 1.00E + 00 | |
Cellular response to heat stress | 5 | 2.6 | 2.00E − 02 | 1.00E + 00 | |
Major pathway of rRNA processing in the nucleolus and cytosol | 7 | 3.7 | 2.10E − 02 | 1.00E + 00 | |
Mitochondrial translation | 5 | 2.6 | 2.30E − 02 | 1.00E + 00 | |
RHOJ GTPase cycle | 4 | 2.1 | 2.60E − 02 | 1.00E + 00 | |
rRNA processing in the nucleus and cytosol | 7 | 3.7 | 2.60E − 02 | 1.00E + 00 | |
Metabolism of nucleotides | 5 | 2.6 | 2.80E − 02 | 1.00E + 00 | |
HIV life cycle | 6 | 3.1 | 2.90E − 02 | 1.00E + 00 | |
Metabolism of amino acids and derivatives | 10 | 5.2 | 3.10E − 02 | 1.00E + 00 | |
rRNA processing | 7 | 3.7 | 3.20E − 02 | 1.00E + 00 | |
rRNA modification in the nucleus and cytosol | 4 | 2.1 | 3.40E − 02 | 1.00E + 00 | |
Insulin-like growth factor-2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs) bind RNA | 2 | 1 | 3.40E − 02 | 1.00E + 00 | |
Regulation of TP53 activity | 6 | 3.1 | 3.80E − 02 | 1.00E + 00 | |
ATF4 activates genes in response to endoplasmic reticulum stress | 3 | 1.6 | 3.90E − 02 | 1.00E + 00 |